1 / 59

The Precautionary Principle

The Precautionary Principle. Managing theoretical risks in public health. Policy Problem. The blood system is confronted with the potential new infectious threat from vCJD Must take measures to protect against this theoretical risk

aviv
Télécharger la présentation

The Precautionary Principle

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. The Precautionary Principle Managing theoretical risks in public health

  2. Policy Problem • The blood system is confronted with the potential new infectious threat from vCJD • Must take measures to protect against this theoretical risk • Must balance theoretical reduction in supply that could be caused by developing a policy

  3. Background

  4. CJD • Most common human TSE • Due to effects of prion • 4 Forms • classical • familial • iatrogenic • variant

  5. Classical CJD • develops in 6th to 8th decade of life • rapidly progressing dementia • cerebellar symptoms • death within 3 to 12 months

  6. Variant CJD • Variant CJD first identified in 1996 in UK • average age of onset 27 • presents with behavioural symptoms • invariably fatal, average duration of symptoms of 14 months

  7. Diagnosis/Treatment • No blood test • No treatment

  8. Policy Challenge

  9. vCJD and the blood supply • First theoretical infectious risk to challenge the Canadian blood system since the Krever Inquiry

  10. UK Events • Concerns soon developed that this condition may be blood transmitted • led to a UK decision to import certain blood product requirements from other countries

  11. Canadian officials immediately began considering whether Canada should use blood from individuals who had traveled to the UK

  12. What information is needed to develop policy? • Risk of transmission of vCJD • Reduction in blood supply of any policy • How much reduction in the blood supply could the sytem sustain

  13. Risk of Transmission of Classical CJD – Case control studies

  14. Risk of Blood Transmission of vCJD • No epidemiological studies • Theoretical Risk • higher prion concentration • affinity for lymphoreticular system • existing model for peripheral transmission (oral)

  15. Impact of Donor Deferral Policies • Full deferral • 22% reduction • 1 month deferral • 10% reduction • 6 month deferral • 3% reduction

  16. Sustainability of Blood Supply Reduction • Blood system had been able to sustain a 3% reduction in supply in the past

  17. What Policy should be instituted?

  18. Options • No policy should be instituted • vCJD is a theoretical risk, there is no epidemiological evidence of harm • A partial policy should be instituted • balances reducing the risk of vCJD with potential harm caused by reducing the blood supply • Full policy should be instituted • even 1 day in the UK puts you at risk

  19. Canadian Response • Canadian blood system embarked upon risk assessment analysis • conducted a systematic evaluation of the impact on supply of a donor deferral policy versus the potential health benefit of such a policy.

  20. Policy Decision • August 1999, policy-makers officially announced that individuals who had traveled to the UK for 6-months between the years 1980 and 1996 would be deferred from donating blood

  21. Is this Evidence-Based Decision-Making?

  22. Factors Influencing Policy Process

  23. Importance of Value Systems on Interpretation of Scientific Information Role of the Precautionary Principle

  24. Limitations of evidence • In 1986 BSE is discovered in the UK • no epidemiological evidence exists of harm, however there is a theoretical risk of transmission • UK chose not to take actions to halt spread of BSE • important health impact, enormous financial impact, undermined confidence in public health

  25. In 1980s concern emerged about potential blood transmission of HIV and Hepatitis C • no epidemiological evidence exists of harm, however there was a theoretical risk of transmission • Canada chose not to take full measures to protect blood supply from HIV, Hep C • enormous health and financial impact, undermined confidence in blood system

  26. Both government responses criticized for not taking precautionary measures

  27. “the safety of the blood supply is an aspect of public health, and, therefore, the blood supply system must be governed by the public health philosophy, which rejects the view that complete knowledge of a public health hazard is a prerequisite for action.” • Justice Krever

  28. The Precautionary Principle • The precautionary principle emerged out of the European environmental movement of the 1970’s and has its roots in the German concept of Vorsorge or foresight.

  29. The principle reflects a recognition of the limitations of scientific models to accurately describe complex issues pertaining to environmental harm or health risk

  30. Impact • Since the time of its introduction, the precautionary principle has had a substantial impact on environmental policy • It has been incorporated into the 1992 Rio Declaration on Environment and Development and the Maastricht Treaty Establishing the European Community

  31. Definition • The precautionary principle essentially states that complete evidence of risk does not have to exist to protect individuals and society from the risk • “Better to be safe than sorry” • “An ounce of prevention is worth a pound of cure”

  32. “When an activity raises threats of harm to human health or the environment, precautionary measures should be taken even if some cause and effect relationships are not fully established scientifically.  In this context the proponent of an activity, rather than the public, should bear the burden of proof.” • Wingspread Statement

  33. “Where there are threats of serious or irreversible damage, lack of full scientific certainty shall not be used as a reason for postponing cost-effective measures to prevent environmental degradation.” • Rio Declaration

  34. Interpretations of the Principle • Stronger interpretations • burden of responsibility on the proponents of potentially harmful measures • Weaker interpretations • burden of proof on those arguing the possibility of harm

  35. Core Concepts • (1) advocating anticipatory action to prevent harm • (2) shifting some of the burden of proof to the proponents of new technologies to demonstrate safety

  36. (3) advocating a consideration of all alternatives to a new technology including doing nothing • (4) incorporation of all affected parties in the decision- making process of adopting a new technology

  37. Problems with Precaution

  38. Policy makers have had difficulty in agreeing on how much or how little evidence is required to trigger a precautionary action and on the role of the scientific process when the principle is utilized

  39. The variability in the interpretation of the principle has led to accusations that the principle has been used as a mechanism to introduce trade protectionism.

  40. The principle has also been accused of • producing over regulation • denying the public the benefits of new technologies • arousing unnecessary fear in the public about theoretical risks

  41. Applications • Primarily has been used in the environmental sector • Increasingly being used in the health sector • Implications of applying an “environmental” measure to the health sector has not been fully examined

  42. Challenge of Balancing Competing Risks • “recognizing that in the application of the precautionary principle strictly to health, that there are some potential problems in exercising restraint … when it involves a therapeutic product, the absence of (which) may in itself have a risk consequence to a patient population”

  43. Is the Precautionary Principle Useful in Public Health?

  44. Double Edged Sword • Environmental Sector • Balance benefits to health and the environment versus economic and technological losses • Health Sector • Balance benefits to health against possible health consequences

  45. Examples of inappropriate Precaution • DDT and environmental harm • Banned because of environmental harm based on animal evidence • Increase in malaria deaths • Chlorine and cancer • Peru banned chlorine because of carcinogenic fears • Cholera outbreak followed • GMO’s and biodiversity • EU banned import of GMO’s due to theoretical fears of harm • Zambia refused large donation of GMO’s in the presence of famine

  46. Proposed Solutions • Proportionality • Non-discrimination • Consistency • Examining costs and benefits • Subject to review • Assigning responsibility for producing scientific evidence

  47. How can the Precautionary Principle be applied? • 4 mechanisms of application of the Precautionary Principle

More Related